First drug price cuts by French authorities

29 July 2001

Less than eight weeks after the launch of the French government's drugcost reduction policy (Marketletter June 18), the first list of drugs for which prices have been reviewed has appeared in the Official Journal. The list contains a total of 37 drug specialties.

The reductions, which have not been precisely indicated, are said to vary according to the product and mainly affect drugs which have been judged as inadequately effective. The cuts will come into force on September 1 this year for 34 items, on October 1 for one other and October 15 for the remaining two.

Some problems expected

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight